40 filings
Page 2 of 2
8-K
c6xva9 2zfvflzi5
10 Nov 22
Indaptus Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update
4:30pm
8-K
fxajz8x1sos738
30 Sep 22
Submission of Matters to a Vote of Security Holders
4:30pm
8-K
nh8by
8 Aug 22
Indaptus Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
8:08am
8-K
3tzscxq on
21 Jul 22
Amendments to Articles of Incorporation or Bylaws
4:34pm
8-K
6nswt4bah5tu2ubzv
1 Jun 22
Entry into a Material Definitive Agreement
5:02pm
8-K
qyt0zmgr5lva 4y1s
19 May 22
Indaptus Therapeutics Announces FDA Clearance of Investigational New Drug
7:51am
8-K
clulpoer
12 May 22
Indaptus Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update
8:16am
8-K
2jkzi ula9uu3s
21 Mar 22
Indaptus Therapeutics Reports Fourth Quarter and Year End 2021 Financial Results and Provides Corporate Update
7:11am
8-K
3pk7yfuyqjo5isfca
1 Feb 22
Departure of Directors or Certain Officers
4:58pm
8-K
luiypya8
3 Jan 22
Indaptus Therapeutics Announces Appointment of Boyan Litchev, M.D. as Chief Medical Officer
7:38am
8-K
l4afo
2 Dec 21
Departure of Directors or Certain Officers
8:00am
8-K
kmol7bicnj8d13h2aq9s
15 Nov 21
Indaptus Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update
7:17am
8-K
7e4ja9
16 Aug 21
Unaudited Financial Statements
4:10pm
8-K/A
85p0jftasq81uo3ij6r1
16 Aug 21
Cost Associated with Exit or Disposal Activities
4:05pm
8-K
5jwvpfpeyb2
6 Aug 21
Intec Closes Merger with Decoy Biosystems
5:29pm
8-K
t9bk 7hs3631n37
6 Aug 21
Intec Closes Merger with Decoy Biosystems
5:29pm
8-K
69a qsrj6k
29 Jul 21
Entry into a Material Definitive Agreement
5:16pm
8-K
kcvtqnjq li
23 Jul 21
Departure of Directors or Certain Officers
4:30pm
8-K
ozksqz xc
16 Jul 21
Other Events
5:11pm
8-K
szitgr
22 Jun 21
Other Events
9:07am